These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 11967509)

  • 1. Severe preeclampsia at <25 weeks of gestation: maternal and neonatal outcomes.
    Jenkins SM; Head BB; Hauth JC
    Am J Obstet Gynecol; 2002 Apr; 186(4):790-5. PubMed ID: 11967509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome versus severe preeclampsia: onset at < or =28.0 weeks' gestation.
    Haddad B; Barton JR; Livingston JC; Chahine R; Sibai BM
    Am J Obstet Gynecol; 2000 Dec; 183(6):1475-9. PubMed ID: 11120513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expectant management of severe preeclampsia at less than 27 weeks' gestation: maternal and perinatal outcomes according to gestational age by weeks at onset of expectant management.
    Bombrys AE; Barton JR; Nowacki EA; Habli M; Pinder L; How H; Sibai BM
    Am J Obstet Gynecol; 2008 Sep; 199(3):247.e1-6. PubMed ID: 18771971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute renal failure complicating severe preeclampsia requiring admission to an obstetric intensive care unit.
    Drakeley AJ; Le Roux PA; Anthony J; Penny J
    Am J Obstet Gynecol; 2002 Feb; 186(2):253-6. PubMed ID: 11854645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expectant management of severe preeclampsia presenting before 25 weeks of gestation.
    Sezik M; Ozkaya O; Sezik HT; Yapar EG
    Med Sci Monit; 2007 Nov; 13(11):CR523-527. PubMed ID: 17968301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia between 34 and 37 weeks' gestation (HYPITAT-II): a multicentre, open-label randomised controlled trial.
    Langenveld J; Broekhuijsen K; van Baaren GJ; van Pampus MG; van Kaam AH; Groen H; Porath M; Oudijk MA; Bloemenkamp KW; Groot CJ; van Beek E; van Huizen ME; Oosterbaan HP; Willekes C; Wijnen-Duvekot EJ; Franssen MT; Perquin DA; Sporken JM; Woiski MD; Bremer HA; Papatsonis DN; Brons JT; Kaplan M; Nij Bijvanck BW; Mol BW;
    BMC Pregnancy Childbirth; 2011 Jul; 11():50. PubMed ID: 21736705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perinatal outcomes in preeclampsia that is complicated by massive proteinuria.
    Newman MG; Robichaux AG; Stedman CM; Jaekle RK; Fontenot MT; Dotson T; Lewis DF
    Am J Obstet Gynecol; 2003 Jan; 188(1):264-8. PubMed ID: 12548227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia after 36 weeks' gestation (HYPITAT): a multicentre, open-label randomised controlled trial.
    Koopmans CM; Bijlenga D; Groen H; Vijgen SM; Aarnoudse JG; Bekedam DJ; van den Berg PP; de Boer K; Burggraaff JM; Bloemenkamp KW; Drogtrop AP; Franx A; de Groot CJ; Huisjes AJ; Kwee A; van Loon AJ; Lub A; Papatsonis DN; van der Post JA; Roumen FJ; Scheepers HC; Willekes C; Mol BW; van Pampus MG;
    Lancet; 2009 Sep; 374(9694):979-988. PubMed ID: 19656558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for adverse maternal outcomes among women with HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome.
    Haddad B; Barton JR; Livingston JC; Chahine R; Sibai BM
    Am J Obstet Gynecol; 2000 Aug; 183(2):444-8. PubMed ID: 10942484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neonatal outcome in severe preeclampsia at 24 to 36 weeks' gestation: does the HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome matter?
    Abramovici D; Friedman SA; Mercer BM; Audibert F; Kao L; Sibai BM
    Am J Obstet Gynecol; 1999 Jan; 180(1 Pt 1):221-5. PubMed ID: 9914607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypertensive disorders in twin versus singleton gestations. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units.
    Sibai BM; Hauth J; Caritis S; Lindheimer MD; MacPherson C; Klebanoff M; VanDorsten JP; Landon M; Miodovnik M; Paul R; Meis P; Thurnau G; Dombrowski M; Roberts J; McNellis D
    Am J Obstet Gynecol; 2000 Apr; 182(4):938-42. PubMed ID: 10764477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Subsequent pregnancy outcome in women with a history of preeclampsia and/or HELLP syndrome].
    Cathelain-Soland S; Coulon C; Subtil D; Houfflin-Debarge V; Deruelle P
    Gynecol Obstet Fertil; 2010 Mar; 38(3):166-72. PubMed ID: 20185355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Adverse Maternal Outcomes between Early- and Late-Onset Superimposed Preeclampsia.
    Onishi K; Seagraves E; Baraki D; Donaldson T; Barake C; Abuhamad A; Huang JC; Kawakita T
    Am J Perinatol; 2024 May; 41(S 01):e2010-e2016. PubMed ID: 37207676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of fetal growth restriction on latency in the setting of expectant management of preeclampsia.
    McKinney D; Boyd H; Langager A; Oswald M; Pfister A; Warshak CR
    Am J Obstet Gynecol; 2016 Mar; 214(3):395.e1-7. PubMed ID: 26767794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence and risk factors for severe preeclampsia, hemolysis, elevated liver enzymes, and low platelet count syndrome, and eclampsia at preterm and term gestation: a population-based study.
    Lisonkova S; Bone JN; Muraca GM; Razaz N; Wang LQ; Sabr Y; Boutin A; Mayer C; Joseph KS
    Am J Obstet Gynecol; 2021 Nov; 225(5):538.e1-538.e19. PubMed ID: 33974902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Criteria of pregnancy termination in women with preeclampsia].
    Haddad B; Louis-Sylvestre C; Doridot V; Touboul C; Abirached F; Paniel BJ
    Gynecol Obstet Fertil; 2002 Jun; 30(6):467-73. PubMed ID: 12146147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Morbidity and mortality of patients with preeclampsia or HELLP syndrome transferred in intensive care].
    Sabbah-Briffaut E; Bourzoufi K; Fourrier F; Subtil D; Houfflin-Debarge V; Deruelle P
    Presse Med; 2009 Jun; 38(6):872-80. PubMed ID: 19186027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency, risk factors and feto-maternal outcomes of abruptio placentae in Northern Tanzania: a registry-based retrospective cohort study.
    Macheku GS; Philemon RN; Oneko O; Mlay PS; Masenga G; Obure J; Mahande MJ
    BMC Pregnancy Childbirth; 2015 Oct; 15():242. PubMed ID: 26446879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maternal and neonatal complications in women with medical comorbidities and preeclampsia.
    Tanner MS; Malhotra A; Davey MA; Wallace EM; Mol BW; Palmer KR
    Pregnancy Hypertens; 2022 Mar; 27():62-68. PubMed ID: 34942478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subsequent pregnancy outcome in women with a history of HELLP syndrome at < or = 28 weeks of gestation.
    Chames MC; Haddad B; Barton JR; Livingston JC; Sibai BM
    Am J Obstet Gynecol; 2003 Jun; 188(6):1504-7; discussion 1507-8. PubMed ID: 12824985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.